Document:

ex4_1.htm

    
      
        

      

    

    Exhibit
4.1

    

      WARRANT

       

      THESE
SECURITIES AND THE UNDERLYING SHARES OF SERIES B STOCK AND COMMON STOCK HAVE NOT
BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY,
MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM,
OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE
SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS
EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE
SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
COMPANY.  THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA
FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A
FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a)
UNDER THE SECURITIES ACT.

       

      STOCK
PURCHASE WARRANT

       

      To
Purchase Shares of Series B Stock or up to 15,000,000 Shares of Common Stock of
RoomLinX, Inc.

       

      THIS
STOCK PURCHASE WARRANT CERTIFIES that, for value received, Creative Hospitality
Associates LLC (the “Holder”), is entitled, upon the terms and subject to the
limitations on exercise and the conditions hereinafter set forth, at any time on
or after the date of the initial vesting of Warrant Shares (as hereinafter
defined) as set forth in Section 2(a) hereof (the “Initial Exercise Date”) and
on or prior to the close of business on the fifth anniversary of the Initial
Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and
purchase from RoomLinX, Inc., a Nevada corporation (the “Company”), shares of
Series B Preferred Stock, par value $.20 per share (“Series B Stock”), in the form of the attached Certificate of
Designation of the Company (the “Series B Warrant Shares”) in such number
and at such purchase price per share (the “Series B Exercise Price”) such that
such Series B Stock would convert into the same number of shares of common stock of the Company, par value $.001 per share (the “Common Stock”) as if the subscription and purchase had in
fact been of shares of Common Stock after the occurrence of the Triggering Event
(as hereinafter defined); provided, however, that upon
the occurrence of the Triggering Event, the
Holder’s unexercised right hereunder to subscribe for and purchase Series
B Stock shall immediately be converted into a right entitling the Holder, upon
the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, to subscribe for and purchase from the Company up to
fifteen million (15,000,000) shares of Common
Stock (the “Common Stock Warrant Shares”; collectively with the Series B Warrant
Shares, the “Warrant Shares”).  The purchase price of one share of
Common Stock (the “Common Stock Exercise Price”) under this Warrant shall be
$.02.  References herein to the
Warrant Shares shall be deemed references to the Series B Warrant Shares and/or
the Common Stock Warrant Shares, as applicable, and references herein to the
Exercise Price shall be deemed references to the Series B Exercise Price and/or
the Common Stock Exercise Price, as applicable.  For purposes hereof,
the “Triggering Event” shall mean and have been deemed to have occurred
immediately upon the delivery from the Company to the Holder of a written
certification that it has a sufficient number of shares of Common Stock
authorized and available to provide for the issuance of the Common Stock Warrant
Shares.  The Exercise Price and the number of Warrant Shares for which
the Warrant is exercisable shall be subject to adjustment as provided
herein.  The Holder acknowledges that the Company is currently
delinquent in its filings under the Securities Exchange Act of 1934, as amended,
and the Company will not be able to effect a Triggering Event until the Company
becomes current on its filings and then obtains the approval of its stockholders
of the Triggering Event and there is no assurance the Company can or will ever
become current on such filings or obtain such stockholder approval and that the
Triggering Event will occur.  Notwithstanding the foregoing, the
Company agrees to use its commercially reasonable best efforts to make such
filings and cause a Triggering Event to occur as soon as
possible.

       

      
        
           

        

        
          
          

          
            

          

        

        
           

        

      

      Section 1. Title to
Warrant.  Prior to the Termination Date and subject to
compliance with applicable laws and Section 7 of this Warrant, this Warrant and
all rights hereunder are transferable, in whole or in part, at the office or
agency of the Company by the Holder in person or by duly authorized attorney,
upon surrender of this Warrant together with the Assignment Form annexed hereto
properly endorsed.  The transferee shall sign an investment
letter substantially in the form attached hereto and
otherwise in form and substance reasonably satisfactory to the
Company.

       

      Section 2. Vesting;
Authorization of Shares.

       

      (a)           500,000
Warrant Shares will irrevocably vest for each 1,000 CHA Rooms.  As
used herein the term “CHA Rooms” shall mean a room in any hotel or other
property (i) that the Holder or an affiliate thereof introduces to the Company
or an affiliate thereof or otherwise facilitates the installation of the RMLX
Media and Entertainment System therein and (ii) in which the RMLX Medial and
Entertainment System is installed.

       

      (b)           The
Company covenants that all Warrant Shares which may be issued upon the exercise
of the purchase rights represented by this Warrant will, upon exercise of the
purchase rights represented by this Warrant in accordance with the provisions of
this Warrant, be duly authorized, validly issued, fully paid and non assessable
and free from all taxes, liens and charges in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with
such issue).

       

      Section 3. Exercise of
Warrant.

       

      (a)           Except
as provided in Section 4 herein, exercise of the purchase rights represented by
this Warrant may be made at any time or times on or after the Initial Exercise
Date and on or before the Termination Date by the surrender of this Warrant and
delivery of the Notice of Exercise form annexed hereto duly executed, at the
office of the Company (or such other office or agency of the Company as it may
designate by notice in writing to the registered Holder at the address of such
Holder appearing on the books of the Company) and upon payment of the Exercise
Price of the Warrant Shares thereby purchased by wire transfer or cashier’s
check drawn on a United States bank, the Holder shall be entitled to receive a
certificate for the number of Warrant Shares so
purchased.  Certificates for shares purchased hereunder shall be
delivered to the Holder within two (2)
trading days after the date on which this Warrant shall have been exercised as
aforesaid. This Warrant shall be deemed to have been exercised and such
certificate or certificates shall be deemed to have been issued, and Holder or
any other person so designated to be named therein shall be deemed to have
become a holder of record of such shares for all purposes, as of the date the
Warrant has been exercised by payment to the Company of the Exercise Price and
all taxes required to be paid by the Holder, if any, pursuant to Section 5 prior
to the issuance of such shares, have been paid.  If the Company fails
to deliver to the Holder a certificate or certificates representing the Warrant
Shares pursuant to this Section 3(a) by the fifth trading day after the date of
exercise, then the Holder will have the right to rescind such
exercise.

       

      
        
           

        

        
          2

          
            

          

        

        
           

        

      

      (b)           At
such time as the Warrant is exercisable for Common Stock Warrant Shares, in lieu
of the payment methods set forth in Section 3(a) above, the Holder may elect to
exchange all or some of the Warrant for Common Stock Warrant Shares equal to the
value of the amount of the Warrant being exchanged on the date of exchange. If
the Holder elects to exchange this Warrant as provided in this Section 3(b), the
Holder shall tender to the Company the Warrant for the amount being exchanged,
along with written notice of the Holder's election to exchange some or all of
the Warrant, and the Company shall issue to the Holder the number of Common
Stock Warrant Shares computed using the following formula:

      

      X = Y (A-B)

                 
A

      

      Where:

      

      X = the
number of Common Stock Warrant Shares to be issued to the Holder;

      

      Y = the
total number of Common Stock Warrant Shares as to which this Warrant is being
exercised;

      

      A = the
Fair Market Value of one share of Common Stock; and

      

      B = the
Purchase Price of one Common Stock Warrant Share (as adjusted to the date of
such calculation).

      

      All
references herein to an "exercise" of the Warrant shall include an exchange
pursuant to this Section 3(b).

      

      (c)           If
this Warrant shall have been exercised in part, when permitted, the Company
shall, at the time of delivery of the certificate or certificates representing
Warrant Shares, provided that this Warrant has been surrendered to the Company,
deliver to Holder a new Warrant evidencing the rights of Holder to purchase the
unpurchased Warrant Shares called for by this Warrant, which new Warrant shall
in all other respects be identical with this Warrant.

       

      
        
           

        

        
          3

          
            

          

        

        
           

        

      

      Section 4. No Fractional
Shares or Scrip.  No fractional shares or scrip representing
fractional shares shall be issued upon the exercise of this
Warrant.

       

      Section 5. Charges, Taxes
and Expenses.  Issuance of certificates for Warrant Shares
shall be made without charge to the Holder for any issue or transfer tax or
other incidental expense in respect of the issuance of such certificate to the
Holder, all of which taxes and expenses shall be paid by the Company, and such
certificates shall be issued in the name of the Holder or in such name or names
as may be directed by the Holder; provided, however, that in the event
certificates for Warrant Shares are to be issued in a name other than the name
of the Holder, this Warrant when surrendered for exercise shall be accompanied
by the Assignment Form attached hereto duly executed by the Holder; and the
Company may require, as a condition thereto, the payment of a sum sufficient to
reimburse it for any transfer tax incidental thereto.

       

      Section 6. Closing of
Books.  The Company will not close its stockholder books or
records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.

       

      Section 7. Transfer,
Division and Combination.

       

      (a)           Subject
to compliance with any applicable securities laws and the conditions set forth
in Sections 1 and 7(e) hereof, this Warrant and all rights hereunder are
transferable, in whole or, upon occurrence of the Triggering Event, in part,
upon surrender of this Warrant at the principal office of the Company, together
with a written assignment of this Warrant substantially in the form attached
hereto duly executed by the Holder or its agent or attorney and funds sufficient
to pay any transfer taxes payable upon the making of such
transfer.  Upon such surrender and, if required, such payment, the
Company shall promptly (but in any event, within 5
days) execute and deliver a new Warrant or Warrants in the name of the
assignee or assignees and in the denomination or denominations specified in such
instrument of assignment, and shall promptly (but
in any event, within 5 days) issue to the assignor a new Warrant
evidencing the portion of this Warrant not so assigned, and this Warrant shall
promptly be cancelled.  A Warrant, if properly assigned, may be
exercised by a new holder for the purchase of Warrant Shares without having a
new Warrant issued.

       

      (b)           This
Warrant may be divided or combined with other Warrants upon presentation hereof
at the aforesaid office of the Company, together with a written notice
specifying the names and denominations in which new Warrants are to be issued,
signed by the Holder or its agent or attorney.  Subject to compliance
with Section 7(a), as to any transfer which may be involved in such division or
combination, the Company shall execute and deliver a new Warrant or Warrants in
exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice.

       

      (c)           The
Company shall prepare, issue and deliver at its own expense (other than transfer
taxes) the new Warrant or Warrants under this Section 7.

       

      (d)           The
Company agrees to maintain, at its aforesaid office, books for the registration
and the registration of transfer of the Warrants.

       

      (e)           If,
at the time of the surrender of this Warrant in connection with any transfer of
this Warrant, the transfer of this Warrant shall not be registered pursuant to
an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws, the Company may require, as a
condition of allowing such transfer, (i) that the Holder or transferee of this
Warrant, as the case may be, furnish to the Company a written opinion of counsel
(which opinion shall be in form, substance and scope customary for opinions of
counsel in comparable transactions) to the effect that such transfer may be made
without registration under the Securities Act and under applicable state
securities or blue sky laws and (ii) that the holder or transferee execute and
deliver to the Company an investment letter
substantially in the form attached hereto and otherwise in form and
substance acceptable to the Company. [Need to create the form]

       

      
        
           

        

        
          4

          
            

          

        

        
           

        

      

      Section 8. No Rights as
Shareholder until Exercise.  This Warrant does not entitle the
Holder to any voting rights or other rights as a shareholder of the Company
prior to the exercise hereof.  Upon the surrender of this Warrant and
the payment of the aggregate Exercise Price, the Warrant Shares so purchased
shall be and be deemed to be issued to such Holder as the record owner of such
shares as of the close of business on the later of the date of such surrender or
payment.

       

      Section 9. Loss, Theft,
Destruction or Mutilation of Warrant.  The Company covenants
that upon receipt by the Company of evidence reasonably satisfactory to it of
the loss, theft, destruction or mutilation of this Warrant or any stock
certificate relating to the Warrant Shares, and in case of loss, theft or
destruction, of indemnity or security reasonably satisfactory to it (which, in
the case of the Warrant, shall not include the posting of any bond), and upon
surrender and cancellation of such Warrant or stock certificate, if mutilated,
the Company will make and deliver a new Warrant or stock certificate of like
tenor and dated as of such cancellation, in lieu of such Warrant or stock
certificate.

       

      Section 10. Saturdays,
Sundays, Holidays, etc.  If the last or appointed day for the
taking of any action or the expiration of any right required or granted herein
shall be a Saturday, Sunday or a legal holiday, then such action may be taken or
such right may be exercised on the next succeeding day not a Saturday, Sunday or
legal holiday.

       

      Section 11. Adjustments of
Exercise Price and Number of Warrant Shares.  The number and
kind of securities purchasable upon the exercise of this Warrant and the
Exercise Price shall be subject to adjustment from time to time upon the
happening of any of the following.  In case the Company shall (i) pay
a dividend in shares of Common Stock or make a distribution in shares of Common
Stock to holders of its outstanding Common Stock, (ii) subdivide its outstanding
shares of Common Stock into a greater number of shares, (iii) combine its
outstanding shares of Common Stock into a smaller number of shares of Common
Stock, or (iv) issue any shares of its capital stock in a reclassification of
the Common Stock, then in each such case the number of Warrant Shares
purchasable upon exercise of this Warrant immediately prior thereto shall be
adjusted so that the Holder shall be entitled to receive the kind and number of
Warrant Shares or other securities of the Company which it would have owned or
have been entitled to receive had such Warrant been exercised in advance thereof
and, if the Triggering Event has not yet occurred, as if the Series B Warrant
Shares which would have been purchased upon such exercise had been converted
into Common Stock in accordance with the conversion rights
thereof.  Upon each such adjustment of the kind and number of Warrant
Shares or other securities of the Company which are purchasable hereunder, the
Holder shall thereafter be entitled to purchase the number of Warrant Shares or
other securities resulting from such adjustment at an Exercise Price per Warrant
Share or other security obtained by multiplying the Exercise Price in effect
immediately prior to such adjustment by the number of Warrant Shares purchasable
pursuant hereto immediately prior to such adjustment and dividing by the number
of Warrant Shares or other securities of the Company resulting from such
adjustment.  An adjustment made pursuant to this paragraph shall
become effective immediately after the effective date of such event retroactive
to the record date, if any, for such event.

       

      
        
           

        

        
          5

          
            

          

        

        
           

        

      

      Section 12. Reorganization,
Reclassification, Merger, Consolidation or Disposition of
Assets.  In case the Company shall reorganize its capital,
reclassify its capital stock, consolidate or merge with or into another
corporation (where the Company is not the surviving corporation or where there
is a change in or distribution with respect to the Common Stock of the Company),
or sell, transfer or otherwise dispose of all or substantially all its property,
assets or business to another corporation and, pursuant to the terms of such
reorganization, reclassification, merger, consolidation or disposition of
assets, shares of common stock of the successor or acquiring corporation, or any
cash, shares of stock or other securities or property of any nature whatsoever
(including warrants or other subscription or purchase rights) in addition to or
in lieu of common stock of the successor or acquiring corporation (“Other
Property”), are to be received by or distributed to the holders of Common Stock
of the Company, then the Holder shall have the right thereafter to receive, at
the option of the Holder, upon exercise of this Warrant, the number of shares of
common stock of the successor or acquiring corporation or of the Company, if it
is the surviving corporation, and Other Property receivable upon or as a result
of such reorganization, reclassification, merger, consolidation or disposition
of assets by a Holder of the number of shares of Common Stock for which this
Warrant is exercisable immediately prior to such event or, had the Triggering
Event occurred, would have been exercisable.

       

      In case
of any such reorganization, reclassification, merger, consolidation or
disposition of assets, the successor or acquiring corporation (if other than the
Company) shall expressly assume the due and punctual observance and performance
of each and every covenant and condition of this Warrant to be performed and
observed by the Company and all the obligations and liabilities hereunder,
subject to such modifications as may be deemed appropriate (as determined in
good faith by resolution of the Board of Directors of the Company) in order to
provide for adjustments of Warrant Shares for which this Warrant is exercisable
which shall be as nearly equivalent as practicable to the adjustments provided
for in this Section 12.  For purposes of this Section 12, “common
stock of the successor or acquiring corporation” shall include stock of such
corporation of any class which is not preferred as to dividends or assets over
any other class of stock of such corporation and which is not subject to
redemption and shall also include any evidences of indebtedness, shares of stock
or other securities which are convertible into or exchangeable for any such
stock, either immediately or upon the arrival of a specified date or the
happening of a specified event and any warrants or other rights to subscribe for
or purchase any such stock.  The foregoing provisions of this Section
12 shall similarly apply to successive reorganizations, reclassifications,
mergers, consolidations or disposition of assets.

       

      Section 13. Voluntary
Adjustment by the Company.  The Company may at any time during
the term of this Warrant reduce the then current Exercise Price to any amount
and for any period of time deemed appropriate by the Board of Directors of the
Company.

       

      
        
           

        

        
          6

          
            

          

        

        
           

        

      

       

      Section 14. Notice of
Adjustment.  Whenever the number of Warrant Shares or number or
kind of securities or other property purchasable upon the exercise of this
Warrant or the Exercise Price is adjusted as herein provided, the Company shall
give prompt written notice thereof to the
Holder, which notice shall state the number of Warrant Shares (and other
securities or property) purchasable upon the exercise of this Warrant and the
Exercise Price of such Warrant Shares (and other securities or property) after
such adjustment, setting forth a brief statement of the facts requiring such
adjustment and setting forth the computation by which such adjustment was
made.

       

      Section 15. Notice of
Corporate Action.  If at any time:

       

      (a) the
Company shall take a record of the holders of its Common Stock for the purpose
of entitling them to receive a dividend or other distribution, or any right to
subscribe for or purchase any evidences of its indebtedness, any shares of stock
of any class or any other securities or property, or to receive any other right,
or

       

      (b) there
shall be any capital reorganization of the Company, any reclassification or
recapitalization of the capital stock of the Company or any consolidation or
merger of the Company with, or any sale, transfer or other disposition of all or
substantially all the property, assets or business of the Company to, another
corporation or,

       

      (c) there
shall be a voluntary or involuntary dissolution, liquidation or winding up of
the Company;

       

      then, in
any one or more of such cases (but not in such cases if the rights of the Holder
or holders of Common Stock will not be materially affected thereby, as for
example in the case of a merger to effect a change of domicile), the Company
shall give to Holder (i) at least 20 days’ prior written notice of the date on
which a record date shall be selected for such dividend, distribution or right
or for determining rights to vote in respect of any such reorganization,
reclassification, merger, consolidation, sale, transfer, disposition,
liquidation or winding up, and (ii) in the case of any such reorganization,
reclassification, merger, consolidation, sale, transfer, disposition,
dissolution, liquidation or winding up, at least 20 days’ prior written notice
of the date when the same shall take place.  Such notice in accordance
with the foregoing clause also shall specify (i) the date on which any such
record is to be taken for the purpose of such dividend, distribution or right,
the date on which the holders of Common Stock shall be entitled to any such
dividend, distribution or right, and the amount and character thereof, and (ii)
the date on which any such reorganization, reclassification, merger,
consolidation, sale, transfer, disposition, dissolution, liquidation or winding
up is to take place and the time, if any such time is to be fixed, as of which
the holders of Common Stock shall be entitled to exchange their Warrant Shares
for securities or other property deliverable upon such disposition, dissolution,
liquidation or winding up in accordance with, as
applicable, Section 12 hereof.  Each such written notice shall
be sufficiently given if addressed to Holder at the last address of Holder
appearing on the books of the Company and delivered in accordance with Section
18(d).

       

      Section 16. Authorized
Shares.  The Company covenants that during the period the
Warrant is outstanding, it will reserve from its authorized and unissued Series
B Stock and, upon the occurrence of the Triggering Event, from its authorized
and unissued Common Stock, a sufficient number of shares to provide for the
issuance of the Warrant Shares upon the exercise of any purchase rights under
this Warrant.  The Company further covenants that its issuance of this
Warrant shall constitute full authority to its officers who are charged with the
duty of executing stock certificates to execute and issue the necessary
certificates for the Warrant Shares upon the exercise of the purchase rights
under this Warrant.  The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided
herein without violation of any applicable law or regulation, or of any
requirements of the trading market upon which the Common Stock may be
listed.

       

      
        
           

        

        
          7

          
            

          

        

        
           

        

      

      Except
and to the extent as waived or consented to in
writing by the Holder, the Company shall not by any action, including,
without limitation, amending its certificate of incorporation or through any
reorganization, transfer of assets, consolidation, merger, dissolution, issue or
sale of securities or any other voluntary action, avoid or seek to avoid the
observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the
taking of all such actions as may be necessary or appropriate to protect the
rights of Holder as set forth in this Warrant against
impairment.  Without limiting the generality of the foregoing, the
Company will (a) not increase the par value of any Warrant Shares above the
amount payable therefor upon such exercise immediately prior to such increase in
par value, (b) take all such action as may be necessary or appropriate in order
that the Company may validly and legally issue fully paid and nonassessable
Warrant Shares upon the exercise of this Warrant, and (c) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents
from any public regulatory body having jurisdiction thereof as may be necessary
to enable the Company to perform its obligations under this
Warrant.

       

      Before
taking any action which would result in an adjustment in the number of Warrant
Shares for which this Warrant is exercisable or in the Exercise Price, the
Company shall obtain all such authorizations or exemptions thereof, or consents
thereto, as may be necessary from any public regulatory body or bodies having
jurisdiction thereof.

       

      Section
17.  Compliance with Securities Laws.

       

      By
acceptance of this Warrant, the Holder hereby represents, warrants and
covenants: (a) that any Warrant Shares purchased upon exercise of the Warrant
shall be acquired for investment only and not with a view to, or for sale in
connection with, any distribution thereof; (b) that the Holder has had such
opportunity as such Holder has deemed adequate to obtain from representatives of
the Company such information as is necessary to permit the Holder to evaluate
the merits and risks of its investment in the Company; (c) that the Holder is
able to bear the economic risk of holding such shares as may be acquired
pursuant to the exercise of this Warrant for an indefinite period; (d) that the
Holder understands that the shares of stock acquired pursuant to the exercise of
this Warrant will not be registered under the Securities Act and will be
"restricted securities" within the meaning of SEC Rule 144 and that the
exemption from registration under Rule 144 will not be available for at least
one year from the date of exercise of this Warrant, and even then will not be
available unless a public market then exists for the stock, adequate information
concerning the Company is then available to the public, and other terms and
conditions of Rule 144 are complied with; and (e) that for a period of one year (after which the Company will
use its commercially reasonable best efforts to enable the resale of the Warrant Shares by the Holder
under Rule 144(b)), all stock
certificates representing Warrant Shares issued to the Holder upon exercise of
this Warrant may have affixed thereto a legend substantially in the following
form:

      
        
           

        

        
          8

          
            

          

        

        
           

        

      

      THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE "ACT"), OR UNDER THE SECURITIES LAWS OF ANY
STATE.  THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON
TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS
PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO
REGISTRATION OR EXEMPTION THEREFROM.

      

      Section 18.
Miscellaneous.

      

      (a)           Jurisdiction.  This
Warrant shall constitute a contract under the laws of the State of Colorado,
without regard to its conflicts of laws principles or rules.

       

      (b)           Restrictions.  The
Holder acknowledges that the Warrant Shares acquired upon the exercise of this
Warrant, if not registered, will have restrictions upon resale imposed by state
and federal securities laws.

       

      (c)           Nonwaiver
and Expenses.  No course of dealing or any delay or failure to
exercise any right hereunder on the part of Holder shall operate as a waiver of
such right or otherwise prejudice Holder’s rights, powers or remedies,
notwithstanding all rights hereunder terminate on the Termination
Date.  If the Company willfully and knowingly fails to comply with any
provision of this Warrant, which results in any material damages to the Holder,
the Company shall pay to Holder such amounts as shall be sufficient to cover any
costs and expenses including, but not limited to, reasonable attorneys’ fees,
including those of appellate proceedings, incurred by Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers
or remedies hereunder.

       

      (d)           Notices.  Any
notice required or permitted by this Warrant shall be in writing and shall be
deemed sufficient upon delivery, when delivered personally or by overnight
courier or sent by fax (upon customary confirmation of receipt), or 48 hours
after being deposited in the U.S. mail, as certified or registered mail, with
postage prepaid, if to the Holder, at the address on record with the Company for
the Holder, and if to the Company, to RoomLinX, Inc., 2150 W. 6th Ave.,
Unit N, Broomfield, CO 80020, Attention: CEO, with a copy to Westerman Ball
Ederer Miller and Sharfstein, LLP, 170 Old Country Road, Suite 400, Mineola, New
York 11501, Attn: Alan Ederer, Esq.

       

      (e)           Limitation
of Liability.  No provision hereof, in the absence of any affirmative
action by Holder to exercise this Warrant or purchase Warrant Shares, and no
enumeration herein of the rights or privileges of Holder, shall give rise to any
liability of Holder for the purchase price of any Common Stock or as a
stockholder of the Company, whether such liability is asserted by the Company or
by creditors of the Company.

       

      
        
           

        

        
          9

          
            

          

        

        
           

        

      

      (f)           Remedies.  Holder,
in addition to being entitled to exercise all rights granted by law, including
recovery of damages, will be entitled to specific performance of its rights
under this Warrant.

       

      (g)           Successors
and Assigns.  Subject to applicable securities laws, this Warrant and
the rights and obligations evidenced hereby shall inure to the benefit of and be
binding upon the successors of the Company and the successors, permitted assigns, heirs and legal beneficiaries of
Holder.  The provisions of this Warrant are intended to be for the
benefit of all Holders from time to time of this Warrant and shall be
enforceable by any such Holder or holder of Warrant Shares.

       

      (h)           Amendment.  This
Warrant may be modified or amended or the provisions hereof waived with the
written consent of the holders of a majority of the then outstanding principal
amount of Convertible Debentures and the Company.

       

      (i)           Severability.  Wherever
possible, each provision of this Warrant shall be interpreted in such manner as
to be effective and valid under applicable law, but if any provision of this
Warrant shall be prohibited by or invalid under applicable law, such provision
shall be ineffective to the extent of such prohibition or invalidity, without
invalidating the remainder of such provisions or the remaining provisions of
this Warrant.

       

      (j)           Headings.  The
headings used in this Warrant are for the convenience of reference only and
shall not, for any purpose, be deemed a part of this Warrant.

       

      [Signature
Page Follows]

       

      
        
          
          

        

        
          10

          
            

          

        

        
          
          

        

      

       

      IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its
officer thereunto duly authorized.

       

      
        	
                Dated:  April 14, 2008

              	 
      	
                ROOMLINX,
      INC.

              
	 
      	 
      	 
      	 
      
	 
      	 
      	
                By:

              	
                /s/
      Michael S. Wasik

              
	 
      	 
      	
                Name:

              	
                Michael S. Wasik

              
	 
      	 
      	
                Title:

              	
                President

              

      

      
        
           

        

        
          11

          
            

          

        

        
           

        

      

      NOTICE
OF EXERCISE

       

      To:
RoomLinX, Inc.

       

      (1)  The
undersigned hereby elects to purchase ________ [circle one: Series B / Common
Stock] Warrant Shares of RoomLinX, Inc. pursuant to the terms of the attached
Warrant, and either [check one]:

       

      ____
tenders herewith payment of the exercise price in full, together with all
applicable transfer taxes, if any, in lawful money of the United
States

       

      or

      

      ____
exercises the Warrant pursuant to the “net exercise” method set forth in Section
3(b) of the Warrant.

       

      (2)  Please
issue a certificate or certificates representing said Warrant Shares in the name
of the undersigned or in such other name as is specified below:

       

      
        	 
      	
                Name:

              	 
      	 
      
	 	 	 	 
	 
      	
                Address:

              	 
      	 
      
	 	 	
                 

                 

              	 
	 
      	 
      	
                 
      

                 

              	 
      
	 	 	 	 
	 
      	
                SS
      or Tax #:

              	 
      	 
      

      

      

      (3)  The
Warrant Shares shall be delivered to the following:

      

      
        	 
      	
                Name:

              	 
      	 
      
	 	 	 	 
	 
      	
                Address:

              	 
      	 
      
	 
      	 
      	
                 
      

                 

              	 
      
	 
      	 
      	
                 
      

                 

              	 
      

      

      

      Warrant
Holder

      

      

      
        	
                By:

              	 
      	 
      
	 
      	
                Name:

              	 
      
	 
      	
                Title:

              	 
      
	 
      	 
      	 
      
	
                Dated:

              	 
      	 
      

      

      
        
           

        

        
          12

          
            

          

        

        
           

        

      

      ASSIGNMENT
FORM

      

      (To
assign the foregoing warrant, execute this form and supply required information.
Do not use this form to exercise the warrant.)

      

      FOR VALUE
RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby
assigned to

      

      _______________________________________________
whose address is

      

      _______________________________________________________________.

      

      _______________________________________________________________

      

      
        	
                Dated:

              	 
      	 
      
	 
      	 
      	 
      
	
                Holder's
      Signature:

              	 
      	 
      
	 
      	 
      	 
      
	
                Holder's
      Address:

              	 
      	 
      
	 
      	
                 
      

                 

              	 
      
	 
      	 
      	 
      
	
                Signature
      Guaranteed:

              	 
      	 
      

      

      

      NOTE:  The
signature to this Assignment Form must correspond with the name as it appears on
the face of the Warrant, without alteration or enlargement or any change
whatsoever, and must be guaranteed by a bank or trust
company.  Officers of corporations and those acting in a fiduciary or
other representative capacity should file proper evidence of authority to assign
the foregoing Warrant.

    

     

     

    13EXHIBIT
      4.1

    SAMPLE
      WARRANT – CASH FORMAT

    

    NEITHER
      THESE SECURITIES NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
      HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
      SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
      REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
      ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
      EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
      AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
      REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
      SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY ACCEPTABLE
      TO THE COMPANY TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
      ACCEPTABLE TO THE COMPANY. THESE SECURITIES AND THE SECURITIES ISSUABLE UPON
      EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE
      MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

    

    MODERN
      MEDICAL MODALITIES CORPORATION

    

    WARRANT

    

    
      	Warrant
              No. M-0XX 	
              Date
                of Original Issuance: XXXXXXXXX

            

    

     

    Modern
      Medical Modalities Corporation, a New Jersey corporation (the “Company”), hereby
      certifies that, for value received, XXXXXXXXXX or its registered assigns (the
      “Holder”), has the right to purchase from the Company up to a total of XXXXXX
      (“xxx-xxxxxxxxxxxxxxxx) shares of common stock, $0.0002 par value per share (the
      “Common Stock”), of the Company (each such share, a “Warrant Share” and all such
      shares, the “Warrant Shares”) at an exercise price equal to $X.XX per share (as
      adjusted from time to time as provided in Section 8, the “Exercise Price”), at
      any time and from time to time from and after the date hereof and through and
      including XXXXXXXXX (the “Expiration Date”).

    

    1.  Registration
      of Transfers.
      The
      Company shall register the transfer of any portion of this Warrant in the
      Warrant Register, upon surrender of this Warrant, with the Form of Assignment
      attached hereto duly completed and signed, to the Company’s transfer agent or to
      the Company at its address specified herein. Upon any such registration or
      transfer, a new warrant to purchase Common Stock, in substantially the form
      of
      this Warrant (any such new warrant, a “New Warrant”), evidencing the portion of
      this Warrant so transferred shall be issued to the transferee and a New Warrant
      evidencing the remaining portion of this Warrant not so transferred, if any,
      shall be issued to the transferring Holder. The acceptance of the New Warrant
      by
      the transferee thereof shall be deemed the acceptance by such transferee of
      all
      of the rights and obligations of a holder of a Warrant.

    

    2.  Exercise
      and Duration of Warrants.
      This
      Warrant shall be exercisable by the registered Holder at any time and from
      time
      to time on or after the date hereof to and including the Expiration Date. At
      11:59 p.m., Eastern Time on the Expiration Date, the portion of this Warrant
      not
      exercised prior thereto shall be and become void and of no value. The Holder
      shall deliver to the Company the exercise notice attached hereto along with
      a
      certified bank check, or wire transfer, in an amount equal to the Exercise
      Price
      multiplied by the number of Warrants being exercised.

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    3.  Delivery
      of Warrant Shares.
      

    

    (a)  Upon
      delivery of the Form of Election to Purchase to the Company (with the attached
      Warrant Shares Exercise Log) at its address for notice set forth in Section
      13
      and upon payment of the Exercise Price multiplied by the number of Warrant
      Shares that the Holder intends to purchase hereunder, the Company shall promptly
      issue and deliver to the Holder a certificate for the Warrant Shares after
      the
      Date of Exercise. 

    

    A
“Date
      of Exercise” means the date on which the Holder shall have delivered to the
      Company (i) the Form of Election to Purchase attached hereto (with the Warrant
      Exercise Log attached to it), appropriately completed and duly signed and (ii)
      payment of the Exercise Price for the number of Warrant Shares so indicated
      by
      the Holder to be purchased.

    

    (b)  Transfer
      Restrictions.

    

    (i)  This
      Warrant and the Warrant Shares may only be disposed of pursuant to an effective
      registration statement under the Securities Act, to the Company or pursuant
      to
      an available exemption from or in a transaction not subject to the registration
      requirements of the Securities Act, and in compliance with any applicable
      federal and state securities laws. In connection with any transfer of this
      Warrant or any Warrant Shares other than pursuant to an effective registration
      statement or to the Company, except as otherwise set forth herein, the Company
      may require the transferor to obtain an opinion of counsel reasonably acceptable
      to the Company to the effect that such transfer does not require registration
      under the Securities Act. Notwithstanding the foregoing, the Company, without
      requiring a legal opinion as described in the immediately preceding sentence,
      hereby consents to and agrees to register on the books of the Company and with
      any transfer agent for the securities of the Company any transfer of this
      Warrant and the Warrant Shares by the Holder to an Affiliate (as defined in
      Rule
      405 under the Securities Act) of the Holder or to one or more funds or managed
      accounts under common management with such Holder, and any transfer among any
      such Affiliates or one or more funds or managed accounts, provided that the
      transferee certifies to the Company that it is an “accredited investor” as
      defined in Rule 501(a) under the Securities Act and that it is acquiring the
      Warrant and the Warrant Shares solely for investment purposes (subject to the
      qualifications hereof). 

    

    (ii)  Warrant
      Shares issued while there is not an effective registration statement covering
      the resale by the Holder of the Warrant Shares (a “Registration Statement”) or
      while the Holder may not resell such Warrant Shares pursuant to Rule 144(k)
      under the Securities Act shall be issued with the following legend:

    

    THESE
      SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
      OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM
      REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
      ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
      EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
      AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
      REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
      SECURITIES LAWS, AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY
      ACCEPTABLE TO THE COMPANY TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE
      REASONABLY ACCEPTABLE TO THE COMPANY.

    

    4.  Charges,
      Taxes and Expenses.
      Issuance and delivery of certificates for shares of Common Stock upon exercise
      of this Warrant shall be made without charge to the Holder for any issue or
      transfer tax, withholding tax, transfer agent fee or other incidental tax or
      expense in respect of the issuance of such certificates, all of which taxes
      and
      expenses shall be paid by the Company; provided, however, that the Company
      shall
      not be required to pay any tax which may be payable in respect of any transfer
      involved in the registration of any certificates for Warrant Shares or Warrants
      in a name other than that of the Holder. The Holder shall be responsible for
      all
      other tax liability that may arise as a result of holding or transferring this
      Warrant or receiving Warrant Shares upon exercise hereof.

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    5.  Replacement
      of Warrant.
      If this
      Warrant is mutilated, lost, stolen or destroyed, the Company shall issue or
      cause to be issued in exchange and substitution for and upon cancellation
      hereof, or in lieu of and substitution for this Warrant, a New Warrant, but
      only
      upon receipt of evidence reasonably satisfactory to the Company of such loss,
      theft or destruction, if requested. Applicants for a New Warrant under such
      circumstances shall also comply with such other reasonable regulations and
      procedures and pay such other reasonable third-party costs as the Company may
      prescribe.

    

    6.  Reservation
      of Warrant Shares.
      The
      Company covenants that it will at all times reserve and keep available out
      of
      the aggregate of its authorized but unissued and otherwise unreserved Common
      Stock, solely for the purpose of enabling it to issue Warrant Shares upon
      exercise of this Warrant as herein provided, the number of Warrant Shares which
      are then issuable and deliverable upon the exercise of this entire Warrant,
      free
      from preemptive rights or any other contingent purchase rights of persons other
      than the Holder (taking into account the adjustments and restrictions of Section
      7). The Company covenants that all Warrant Shares so issuable and deliverable
      shall, upon issuance and the payment of the applicable Exercise Price in
      accordance with the terms hereof, be duly and validly authorized, issued and
      fully paid and nonassessable.

    

    7.  Certain
      Adjustments.
      The
      Exercise Price and number of Warrant Shares issuable upon exercise of this
      Warrant are subject to adjustment from time to time as set forth in this Section
      7.

    

    (a)  Stock
      Dividends and Splits.
      If the
      Company, at any time while this Warrant is outstanding, (i) pays a stock
      dividend on its Common Stock or otherwise makes a distribution on any class
      of
      capital stock that is payable in shares of Common Stock, (ii) subdivides
      outstanding shares of Common Stock into a larger number of shares, or (iii)
      combines outstanding shares of Common Stock into a smaller number of shares,
      then in each such case the Exercise Price shall be multiplied by a fraction
      of
      which the numerator shall be the number of shares of Common Stock outstanding
      immediately before such event and of which the denominator shall be the number
      of shares of Common Stock outstanding immediately after such event. Any
      adjustment made pursuant to clause (i) of this paragraph shall become effective
      immediately after the record date for the determination of stockholders entitled
      to receive such dividend or distribution, and any adjustment pursuant to clause
      (ii) or (iii) of this paragraph shall become effective immediately after the
      effective date of such subdivision or combination.

    

    (b)  Fundamental
      Transactions.
      If, at
      any time while this Warrant is outstanding, (i) the Company effects any merger
      or consolidation of the Company with or into another Person, (ii) the Company
      effects any sale of all or substantially all of its assets in one or a series
      of
      related transactions, (iii) any tender offer or exchange offer (whether by
      the
      Company or another Person) is completed pursuant to which holders of Common
      Stock are permitted to tender or exchange their shares for other securities,
      cash or property, or (iv) the Company effects any reclassification of the Common
      Stock or any compulsory share exchange pursuant to which the Common Stock is
      effectively converted into or exchanged for other securities, cash or property
      (in any such case, a “Fundamental Transaction”), then the Holder shall have the
      right thereafter to receive, upon exercise of this Warrant, the same amount
      and
      kind of securities, cash or property as it would have been entitled to receive
      upon the occurrence of such Fundamental Transaction if it had been, immediately
      prior to such Fundamental Transaction, the holder of the number of Warrant
      Shares then issuable upon exercise in full of this Warrant (the “Alternate
      Consideration”). The aggregate Exercise Price for this Warrant will not be
      affected by any such Fundamental Transaction, but the Company shall apportion
      such aggregate Exercise Price among the Alternate Consideration in a reasonable
      manner reflecting the relative value of any different components of the
      Alternate Consideration. If holders of Common Stock are given any choice as
      to
      the securities, cash or property to be received in a Fundamental Transaction,
      then the Holder shall be given the same choice as to the Alternate Consideration
      it receives upon any exercise of this Warrant following such Fundamental
      Transaction. In addition, at the Holder’s request, any successor to the Company
      or surviving entity in such Fundamental Transaction shall issue to the Holder
      a
      new warrant consistent with the foregoing provisions and evidencing the Holder’s
      right to purchase the Alternate Consideration for the aggregate Exercise Price
      upon exercise thereof. 

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    (c)  Number
      of Warrant Shares.
      Simultaneously with any adjustment to the Exercise Price pursuant to paragraph
      (a) of this Section, the number of Warrant Shares that may be purchased upon
      exercise of this Warrant shall be increased or decreased proportionately, so
      that after such adjustment the aggregate Exercise Price payable hereunder for
      the increased or decreased number of Warrant Shares shall be the same as the
      aggregate Exercise Price in effect immediately prior to such adjustment.

    

    (d)  Calculations.
      All
      calculations under this Section 7 shall be made to the nearest cent or the
      nearest 1/100th of a share, as applicable. The number of shares of Common Stock
      outstanding at any given time shall not include shares owned or held by or
      for
      the account of the Company, and the disposition of any such shares shall be
      considered an issue or sale of Common Stock.

    

    (e)  Notice
      of Adjustments.
      Upon
      the occurrence of each adjustment pursuant to this Section 7, the Company at
      its
      expense will promptly compute such adjustment in accordance with the terms
      of
      this Warrant and prepare a certificate setting forth such adjustment, including
      a statement of the adjusted Exercise Price and adjusted number or type of
      Warrant Shares or other securities issuable upon exercise of this Warrant (as
      applicable), describing the transactions giving rise to such adjustments and
      showing in detail the facts upon which such adjustment is based. Upon written
      request, the Company will promptly deliver a copy of each such certificate
      to
      the Holder.

    

    (f)  Payment
      of Exercise Price.
      Except
      as otherwise provided in Section 2(b), the Holder shall pay the Exercise Price
      in cash, by certified or bank check, or by wire transfer of immediately
      available funds, in lawful money of the United States.

    

    8.  No
      Fractional Shares.
      No
      fractional shares of Warrant Shares will be issued in connection with any
      exercise of this Warrant. In lieu of any fractional shares which would,
      otherwise be issuable, the Company shall pay cash equal to the product of such
      fraction multiplied by the closing price of one Warrant Share as reported on
      the
      OTC, any stock exchange, market or trading facility on which the Common Stock
      is
      then listed on the date of exercise.

    

    9.  Exchange
      Act Filings.
      The
      Holder agrees and acknowledges that it shall have sole responsibility for making
      any applicable filings with the Securities and Exchange Commission pursuant
      to
      Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, as a
      result of its acquisition of this Warrant and the Warrant Shares and any future
      retention or transfer thereof.

    

    10.  Notices.
      Any and
      all notices or other communications or deliveries hereunder (including without
      limitation any Exercise Notice) shall be in writing and shall be deemed given
      and effective on the earliest of (i) the date of transmission, if such notice
      or
      communication is delivered via facsimile at the facsimile number specified
      in
      this Section at or prior to 5:00 p.m. (Eastern Time) on a trading day, (ii)
      the
      next trading day after the date of transmission, if such notice or communication
      is delivered via facsimile at the facsimile number specified in this Section
      on
      a day that is not a trading day or later than 5:00 p.m. (Eastern Time) on any
      trading day, (iii) the trading day following the date of mailing, if sent by
      nationally recognized overnight courier service, or (iv) upon actual receipt
      by
      the party to whom such notice is required to be given. The addresses for such
      communications shall be: (i) if to the Company, to Modern Medical Modalities
      Corporation, 439 Chestnut Street, Union, NJ 07083 facsimile: (908) 845-0385,
      Attn: Chief Executive Officer, or (ii) if to the Holder, to the address or
      facsimile number appearing on the Warrant Register or such other address or
      facsimile number as the Holder may provide to the Company in accordance with
      this Section. 

    

    11.  Warrant
      Agent.
      The
      Company shall serve as warrant agent under this Warrant. Upon 30 days’ notice to
      the Holder, the Company may appoint a new warrant agent. Any corporation into
      which the Company or any new warrant agent may be merged or any corporation
      resulting from any consolidation to which the Company or any new warrant agent
      shall be a party or any corporation to which the Company or any new warrant
      agent transfers substantially all of its corporate trust or shareholders
      services business shall be a successor warrant agent under this Warrant without
      any further act. Any such successor warrant agent shall promptly cause notice
      of
      its succession as warrant agent to be mailed (by first class mail, postage
      prepaid) to the Holder at the Holder’s last address as shown on the Warrant
      Register.

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    12.  Miscellaneous.

    

    (a)  This
      Warrant shall be binding on and inure to the benefit of the parties hereto
      and
      their respective successors and assigns. Subject to the preceding sentence,
      nothing in this Warrant shall be construed to give to any Person other than
      the
      Company and the Holder any legal or equitable right, remedy or cause of action
      under this Warrant. This Warrant may be amended only in writing signed by the
      Company and the Holder and their successors and assigns.

    

    (b)  All
      questions concerning the construction, validity, enforcement and interpretation
      of this Warrant shall be governed by and construed and enforced in accordance
      with the internal laws of the State of New Jersey, without regard to the
      principles of conflicts of law thereof. Each party hereto (including its
      affiliates, agents, officers, directors and employees) hereby irrevocably
      waives, to the fullest extent permitted by applicable law, any and all right
      to
      trial by jury in any legal proceeding arising out of or relating to this Warrant
      or the transactions contemplated hereby. If either party shall commence an
      action or proceeding to enforce any provisions of this Warrant, then the
      prevailing party in such action or proceeding shall be reimbursed by the other
      party for its attorney’s fees and other costs and expenses incurred with the
      investigation, preparation and prosecution of such action or
      proceeding.

    

    (c)  The
      headings herein are for convenience only, do not constitute a part of this
      Warrant and shall not be deemed to limit or affect any of the provisions
      hereof.

    

    (d)  In
      case
      any one or more of the provisions of this Warrant shall be invalid or
      unenforceable in any respect, the validity and enforceability of the remaining
      terms and provisions of this Warrant shall not in any way be affected or
      impaired thereby and the parties will attempt in good faith to agree upon a
      valid and enforceable provision which shall be a commercially reasonable
      substitute therefore, and upon so agreeing, shall incorporate such substitute
      provision in this Warrant.

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    [REMAINDER
      OF PAGE INTENTIONALLY LEFT BLANK,

    SIGNATURE
      PAGE FOLLOWS]

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    IN
      WITNESS WHEREOF, the Company has caused this Warrant to be duly executed by
      its
      authorized officer as of the date first indicated above.

    

      
        	
                MODERN
                  MEDICAL MODALITITES CORPORATION

              
	 
	 	 
	
                By:
                  

              	 
	
                Name:
                  

              	 
	
                Title:
                  

              	 

      

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    FORM
      OF
      ELECTION TO PURCHASE

    

    To
      Modern
      Medical Modalities Corporation:

    

    In
      accordance with the Warrant enclosed with this Form of Election to Purchase,
      the
      undersigned hereby irrevocably elects to purchase _____________ shares of common
      stock (“Common Stock”), $0.0002 par value per share, of Modern Medical
      Modalities Corporation. The undersigned herewith makes payment of $____________,
      representing the full purchase price for such shares at the Exercise Price
      provided for in such Warrant, together with any applicable taxes payable by
      the
      undersigned pursuant to the Warrant. Such payment takes the form of (check
      applicable box or boxes):

    

    o
      $______ in lawful money
      of the United States; and/or

     

    
      
        
          
            
              	
                    	 	
                      o
                        The cancellation of such portion of
                        the attached Warrant as is exercisable for a total of _____
                        Warrant Shares
                        (using a Fair Market Value of $_____ per share for purposes
                        of this
                        calculation).

                    

            

          

        

      

    

    

    

    The
      undersigned requests that certificates for the shares of Common Stock issuable
      upon this exercise be issued in the name of:

    

      
        	 
	
                (Name)

              
	 
	
                 

              
	
                (Address)

              
	 
	
                 

              
	
                (SSN
                  or Tax ID No.)

              

      

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    Warrant
      Shares Exercise Log

    

      
        	
                Date

              	 	
                Number
                  of Warrant
Shares Available to be
Exercised

              	 	
                Number
                  of Warrant
Shares Exercised

              	 	
                Number
                  of Warrant
Shares Remaining to be
Exercised

              
	 	 	 	 	 	 	 

      

    

    

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    

    FORM
      OF
      ASSIGNMENT

    

    [To
      be
      completed and signed only upon transfer of Warrant]

    

    FOR
      VALUE
      RECEIVED, the undersigned hereby sells, assigns and transfers unto
      ________________________________ the right represented by the within Warrant
      to
      purchase ____________ shares of Common Stock of Modern Medical Modalities
      Corporation to which the within Warrant relates and appoints ________________
      attorney to transfer said right on the books of Modern Medical Modalities
      Corporation with full power of substitution in the premises.

    

    Dated: _______________,
      ____

    

      
        	
                 

              	
              
	
                (Signature
                  must conform in all respects to name of holder as specified on
                  the face of
                  the Warrant)

              
	 
	
                 

              	
              
	
                Address
                  of Transferee

              
	 
	
                 

              	
              
	 
	
                 

              	
              

      

    

    

    In
      the
      presence of:

    __________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00140-of-00352.parquet"}]]